Beijing Med-Pharm Corporation Joins the Russell 3000 Index.PLYMOUTH MEETING, Pa. -- Beijing Med-Pharm Corporation (Nasdaq: BJGP BJGP British Journal of General Practice ) today announced that it has joined the broad-market Russell 3000[R] Index, as the Russell Investment Group Russell Investment Group is an investment firm with global reach, providing investment products and services to individuals and institutions in 44 countries. A pioneer in multi-manager investing, and the creator of Russell Indexes, Russell manages more than US$200 billion in assets confirmed additions to its annually reconstituted set of U.S. and global equity indexes. Membership in the Russell 3000, which remains effective for one year, incorporates Beijing Med-Pharm into the Russell 2000 Index Russell 2000 Index An index measuring the performance of the 2,000 smallest companies in the Russell 3000 Index, which is made up of 3,000 of the biggest U.S. stocks. The Russell 2000 serves as a benchmark for small-cap stocks in the United States. , the Russell Micro-Cap Index, and the Russell Global Index. The Russell 3000 now serves as the U.S. component of the Russell Global Index, launched earlier this year. "We are very pleased to have earned a place on this prestigious index," said David Gao, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Beijing Med-Pharm. "Joining the Russell 3000 is another milestone in our growth as a public company and will contribute to our visibility among several broad peer groups." Russell indexes Russell Indexes US equity index widely used by pension and mutual fund investors that are weighted by market capitalization and published by the Frank Russell Company of Tacoma, Washington. are widely used by investment managers and institutional investors Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $4 trillion in assets currently are benchmarked to them. Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization Total Market Capitalization The total market value of all of a firm's outstanding securities. . The largest 1,000 companies in this ranking comprise the Russell 1000 and the next 2,000 companies become the Russell 2000. Russell's indexes are unmanaged and cannot be invested in directly. More information about the Russell Investment Group and Russell indexes is available at www.russell.com. About Beijing Med-Pharm Corporation Beijing Med-Pharm is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of high-value branded pharmaceutical products in China and pursuing partnerships with other companies seeking to enter the Chinese pharmaceuticals market. Beijing Med-Pharm is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical distribution to hospitals through a unique proprietary network; and pharmaceutical marketing to physicians, hospitals and other healthcare providers. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion